These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16488033)

  • 1. Nanoparticles as targeting ligands.
    Jain KK
    Trends Biotechnol; 2006 Apr; 24(4):143-5. PubMed ID: 16488033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotechnology and aptamers: applications in drug delivery.
    Levy-Nissenbaum E; Radovic-Moreno AF; Wang AZ; Langer R; Farokhzad OC
    Trends Biotechnol; 2008 Aug; 26(8):442-9. PubMed ID: 18571753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges to macromolecular drug delivery.
    Juliano R
    Biochem Soc Trans; 2007 Feb; 35(Pt 1):41-3. PubMed ID: 17233596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the urokinase plasminogen activator receptor with synthetic self-assembly nanoparticles.
    Wang M; Löwik DW; Miller AD; Thanou M
    Bioconjug Chem; 2009 Jan; 20(1):32-40. PubMed ID: 19099499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localized functionalization of individual colloidal carriers for cell targeting and imaging.
    Yake AM; Zahr AS; Jerri HA; Pishko MV; Velegol D
    Biomacromolecules; 2007 Jun; 8(6):1958-65. PubMed ID: 17477569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidimensional atomic force microscopy for drug discovery: a versatile tool for defining targets, designing therapeutics and monitoring their efficacy.
    Lal R; Arnsdorf MF
    Life Sci; 2010 Apr; 86(15-16):545-62. PubMed ID: 20359578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gold nanoparticles as a versatile platform for optimizing physicochemical parameters for targeted drug delivery.
    Bergen JM; von Recum HA; Goodman TT; Massey AP; Pun SH
    Macromol Biosci; 2006 Jul; 6(7):506-16. PubMed ID: 16921538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticles for drug delivery to the lungs.
    Sung JC; Pulliam BL; Edwards DA
    Trends Biotechnol; 2007 Dec; 25(12):563-70. PubMed ID: 17997181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of nanotechnology in biomedicine.
    Navalakhe RM; Nandedkar TD
    Indian J Exp Biol; 2007 Feb; 45(2):160-5. PubMed ID: 17375555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances and challenges of nanotechnology-based drug delivery systems.
    Jiang W; Kim BY; Rutka JT; Chan WC
    Expert Opin Drug Deliv; 2007 Nov; 4(6):621-33. PubMed ID: 17970665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A specific drug targeting system based on polyhydroxyalkanoate granule binding protein PhaP fused with targeted cell ligands.
    Yao YC; Zhan XY; Zhang J; Zou XH; Wang ZH; Xiong YC; Chen J; Chen GQ
    Biomaterials; 2008 Dec; 29(36):4823-30. PubMed ID: 18824258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Click chemistry functionalized polymeric nanoparticles target corneal epithelial cells through RGD-cell surface receptors.
    Lu J; Shi M; Shoichet MS
    Bioconjug Chem; 2009 Jan; 20(1):87-94. PubMed ID: 19099361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of nanoparticle-antibody conjugations: carbodiimide versus click chemistry.
    Thorek DL; Elias DR; Tsourkas A
    Mol Imaging; 2009; 8(4):221-9. PubMed ID: 19728976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticles and microparticles as vaccine-delivery systems.
    Singh M; Chakrapani A; O'Hagan D
    Expert Rev Vaccines; 2007 Oct; 6(5):797-808. PubMed ID: 17931159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, in vitro and in vivo evaluation of radiolabeled nanoparticles.
    Shokeen M; Fettig NM; Rossin R
    Q J Nucl Med Mol Imaging; 2008 Sep; 52(3):267-77. PubMed ID: 18475250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Charge-directed targeting of antimicrobial protein-nanoparticle conjugates.
    Satishkumar R; Vertegel A
    Biotechnol Bioeng; 2008 Jun; 100(3):403-12. PubMed ID: 18183633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active targeting of brain tumors using nanocarriers.
    Béduneau A; Saulnier P; Benoit JP
    Biomaterials; 2007 Nov; 28(33):4947-67. PubMed ID: 17716726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Composite nanoparticles take aim at cancer.
    Gil PR; Parak WJ
    ACS Nano; 2008 Nov; 2(11):2200-5. PubMed ID: 19206383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of gelatin nanoparticles with biotinylated EGF conjugation for lung cancer targeting.
    Tseng CL; Wang TW; Dong GC; Yueh-Hsiu Wu S; Young TH; Shieh MJ; Lou PJ; Lin FH
    Biomaterials; 2007 Sep; 28(27):3996-4005. PubMed ID: 17570484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Status of novel drug delivery technology for phytotherapeutics.
    Musthaba SM; Baboota S; Ahmed S; Ahuja A; Ali J
    Expert Opin Drug Deliv; 2009 Jun; 6(6):625-37. PubMed ID: 19505192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.